SEC Form 4 · accession 0001415889-16-007051
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond F Schinazi
Director · 10% Owner
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | P | 4,878,050 | $0.41 | A | 4,878,050 | I | By LLC |
| Common Stock | holding | — | — | — | 275,520,853 | D |
Table II — derivative securities
No Table II lines on this filing.